These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34926534)

  • 1. LncRNA MSC-AS1 Is a Diagnostic Biomarker and Predicts Poor Prognosis in Patients With Gastric Cancer by Integrated Bioinformatics Analysis.
    Yang W; Ge F; Lu S; Shan Z; Peng L; Chai J; Liu H; Li B; Zhang Z; Huang J; Hua Y; Zhang Y
    Front Med (Lausanne); 2021; 8():795427. PubMed ID: 34926534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of lncRNA AGAP2-AS1 is an independent predictor of poor survival in patients with clear cell renal carcinoma.
    Gao L; Zhao A; Wang X
    Oncol Lett; 2020 Jun; 19(6):3993-4001. PubMed ID: 32382344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA MIR4435-2HG predicts poor prognosis in patients with colorectal cancer.
    Ouyang W; Ren L; Liu G; Chi X; Wei H
    PeerJ; 2019; 7():e6683. PubMed ID: 30972258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAXIP1-AS1 is associated with immune infiltration and predicts poor prognosis in ovarian cancer.
    Chen B; Lu X; Zhou Q; Chen Q; Zhu S; Li G; Liu H
    PLoS One; 2023; 18(8):e0290031. PubMed ID: 37582104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Expression of POSTN Predicts Poor Prognosis: a Potential Therapeutic Target for Gastric Cancer.
    Lu S; Peng L; Ma F; Chai J; Hua Y; Yang W; Zhang Z
    J Gastrointest Surg; 2023 Feb; 27(2):233-249. PubMed ID: 36451060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HTRA3 Is a Prognostic Biomarker and Associated With Immune Infiltrates in Gastric Cancer.
    Ji C; Sun LS; Xing F; Niu N; Gao HL; Dai JW; Zhou N; Jiang BC
    Front Oncol; 2020; 10():603480. PubMed ID: 33425760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA ST7-AS1 is a Potential Novel Biomarker and Correlated With Immune Infiltrates for Breast Cancer.
    Zhang Z; Zhang H; Li D; Zhou X; Wang J; Zhang Q
    Front Mol Biosci; 2021; 8():604261. PubMed ID: 33912584
    [No Abstract]   [Full Text] [Related]  

  • 8. LncRNA WEE2-AS1 is a diagnostic biomarker that predicts poor prognoses in patients with glioma.
    Zhu X; Chen D; Sun Y; Yang S; Wang W; Liu B; Gao P; Li X; Wu L; Ma S; Lin W; Ma J; Yan D
    BMC Cancer; 2023 Feb; 23(1):120. PubMed ID: 36747161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of immune infiltration-related LncRNA FAM83C-AS1 for predicting prognosis and immunotherapy response in colon cancer.
    Li G; Feng H; Chen Q; Xue C; Li M; Liu X; Ma S
    Transpl Immunol; 2021 Dec; 69():101481. PubMed ID: 34624486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCDC68 predicts poor prognosis in patients with colorectal cancer: a study based on TCGA data.
    Zhang W; Xu TT; An ZT; Wei LF; Gu C; Li H; Tian YZ
    J Gastrointest Oncol; 2022 Apr; 13(2):657-671. PubMed ID: 35557589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DDX59-AS1 is a prognostic biomarker and correlated with immune infiltrates in OSCC.
    Sun Y; Zhou Q; Sun J; Bi W; Li R; Wu X; Li N; Song L; Yang F; Yu Y
    Front Genet; 2022; 13():892727. PubMed ID: 36081993
    [No Abstract]   [Full Text] [Related]  

  • 12. High LYRM4-AS1 predicts poor prognosis in patients with glioma and correlates with immune infiltration.
    Wang HY; Xie Y; Du H; Luo B; Li Z
    PeerJ; 2023; 11():e16104. PubMed ID: 37810780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LINC01094 Predicts Poor Prognosis in Patients With Gastric Cancer and is Correlated With EMT and Macrophage Infiltration.
    Ye Y; Ge O; Zang C; Yu L; Eucker J; Chen Y
    Technol Cancer Res Treat; 2022; 21():15330338221080977. PubMed ID: 35254147
    [No Abstract]   [Full Text] [Related]  

  • 14. Upregulation of OTX2-AS1 is Associated With Immune Infiltration and Predicts Prognosis of Gastric Cancer.
    Han QL; Cui Z; Wang Q; Pang F; Li D; Wang D
    Technol Cancer Res Treat; 2023; 22():15330338231154091. PubMed ID: 36740995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA FOXP4-AS1 is a prognostic biomarker and associated with immune infiltrates in ovarian serous cystadenocarcinoma.
    Liao C; Wang A; Ma Y; Liu H
    Medicine (Baltimore); 2021 Oct; 100(40):e27473. PubMed ID: 34622876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bioinformatics analysis of the association between long non-coding RNA ubiquitin-specific peptidase 30 antisense RNA 1 (lncRNA USP30-AS1) and immune cell infiltration in ovarian serous cystadenocarcinoma].
    Wang H; Huang S; Meng Q; Zhang J; Wei L
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Sep; 39(9):834-840. PubMed ID: 37732580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA DIRC1 is a novel prognostic biomarker and correlated with immune infiltrates in stomach adenocarcinoma.
    Lin Y; Zhang Z; Li Y; Chen Y; Su M; Zhao W
    Medicine (Baltimore); 2022 Nov; 101(46):e31839. PubMed ID: 36401393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDCA8 as an independent predictor for a poor prognosis in liver cancer.
    Shuai Y; Fan E; Zhong Q; Chen Q; Feng G; Gou X; Zhang G
    Cancer Cell Int; 2021 Mar; 21(1):159. PubMed ID: 33685433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel LncRNA ZFHX4-AS1 as a Potential Prognostic Biomarker That Affects the Immune Microenvironment in Ovarian Cancer.
    Wang X; Wang Y; Sun F; Xu Y; Zhang Z; Yang C; Zhang L; Lou G
    Front Oncol; 2022; 12():945518. PubMed ID: 35903691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis and promotes malignant phenotypes in gastric cancer.
    Feng Y; Zhang Q; Wang J; Liu P
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3842-3849. PubMed ID: 28975981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.